El teatro escolar como estrategia didáctica en el desarrollo de la comprensión lectora en el 3er grado, turno matutino en la Escuela Pública Santa Clara del Municipio de Ciudad Darío, departamento de Matagalpa durante el II semestre del año lectivo 2021

Dentro de la presente investigación se plantea el teatro escolar como estrategia didáctica que favorece a la comprensión de los estudiantes del 3er grado de la Escuela Pública Santa Clara durante el año lectivo 2021. Teniendo en cuenta como objetivo principal el desarrollo de la comprensión lectora en los estudiantes del tercer grado se desarrolla el plan de acción con el fin de dar respuesta a la hipótesis planteada dentro de la investigación y de esta forma dar alternativas de solución a la problemática del comprender textos en estudiantes del tercer grado. Para la recopilación de la información presentada en el presente documento se hizo uso de técnicas e instrumentos tales como el conversatorio, guía de observación, clases demostrativas, monitoreo y seguimiento a la estrategia. Fue posible recolectar la información y gracias a eso tener un mejor panorama acerca de las dificultades y problemáticas que se encuentran dentro del salón de clases. Como parte del marco referencial que acompaña la investigación se presentan las contextualizaciones del teatro como estrategia didáctica y sus elementos para ponerla en práctica en el aula de clases. De tal forma que se diseña la estrategia didáctica, con el fin de brindar una estrategia nueva a la docente y que los estudiantes alcancen el objetivo de la clase, el cual es mejorar la comprensión lectora, ya que fue posible encontrar dificultades al comprender lo que leían, por otro lado, fue posible apreciar clases desarrolladas de forma tradicional. Se pretende que la implementación del teatro como estrategia didáctica, de respuestas factibles a las problemáticas encontradas en el aula de clas

Análisis de la convencionalidad del juzgamiento en ausencia en materia penal

This article analyses the international legality of the trial in absentia in the Colombian criminal procedure. Although the Colombian Constitutional Court hat affirms that this figure is accord to the Colombian Constitution, the authors of this article can affirm that the Colombian trial in absentia is against the due process of law as it is established in the international law of human rights.El presente artículo pretende analizar la convencionalidad de una institución procesal cuya legitimidad y validez se da por descontada, pero que, en realidad, riñe con nociones básicas de justicia asociadas al debido proceso. Con tal propósito, los autores estudian el desarrollo de la figura del juzgamiento en ausencia en la jurisprudencia de los principales tribunales internacionales en materia de derechos humanos y de los tribunales penales internacionales y mixtos, para concluir que esta figura, tal como está consagrado en Colombia, riñe con el derecho internacional de los derechos humanos. Finalmente, se valoran los argumentos sostenidos por la Corte Constitucional para afirmar la constitucionalidad para de la figura de la declaratoria de persona ausente y se demuestra que estos no resisten no un análisis serio desde el DIDH

In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19

Background: There is pressing urgency to identify therapeutic targets and drugs that allow treating COVID-19 patients effectively.Methods: We performed in silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks to reveal potential therapeutic targets for drug repurposing against COVID-19.Results: We screened 1,584 high-confidence immune system proteins in ACE2 and TMPRSS2 co-expressing cells, finding 25 potential therapeutic targets significantly overexpressed in nasal goblet secretory cells, lung type II pneumocytes, and ileal absorptive enterocytes of patients with several immunopathologies. Then, we performed fully connected deep neural networks to find the best multitask classification model to predict the activity of 10,672 drugs, obtaining several approved drugs, compounds under investigation, and experimental compounds with the highest area under the receiver operating characteristics.Conclusion: After being effectively analyzed in clinical trials, these drugs can be considered for treatment of severe COVID-19 patients. Scripts can be downloaded at

Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines

Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. Over the years 2 different schools have developed their strategies: the United States (US) and the European. Allergen extracts available in these regions are adapted to local practice. In other parts of the world, extracts from both regions and local ones are commercialized, as in Mexico. Here, local experts developed a national AIT guideline (GUIMIT 2019) searching for compromises between both schools. Methods: Using ADAPTE methodology for transculturizing guidelines and AGREE-II for evaluating guideline quality, GUIMIT selected 3 high-quality Main Reference Guidelines (MRGs): the European Academy of Allergy, Asthma and Immunology (EAACI) guideines, the S2k guideline of various German-speaking medical societies (2014), and the US Practice Parameters on Allergen Immunotherapy 2011. We formulated clinical questions and based responses on the fused evidence available in the MRGs, combined with local possibilities, patient's preference, and costs. We came across several issues on which the MRGs disagreed. These are presented here along with arguments of GUIMIT members to resolve them. GUIMIT (for a complete English version, see Supplementary data) concluded the following: Results: Related to the diagnosis of IgE-mediated respiratory allergy, apart from skin prick testing complementary tests (challenges, in vitro testing and molecular such as species-specific allergens) might be useful in selected cases to inform AIT composition. AIT is indicated in allergic rhinitis and suggested in allergic asthma (once controlled) and IgE-mediated atopic dermatitis. Concerning the correct subcutaneous AIT dose for compounding vials according to the US school: dosing tables and formula are given; up to 4 non-related allergens can be mixed, refraining from mixing high with low protease extracts. When using European extracts: the manufacturer's indications should be followed; in multi-allergic patients 2 simultaneous injections can be given (100% consensus); mixing is discouraged. In Mexico only allergoid tablets are available; based on doses used in all sublingual immunotherapy (SLIT) publications referenced in MRGs, GUIMIT suggests a probable effective dose related to subcutaneous immunotherapy (SCIT) might be: 50–200% of the monthly SCIT dose given daily, maximum mixing 4 allergens. Also, a table with practical suggestions on non-evidence-existing issues, developed with a simplified Delphi method, is added. Finally, dissemination and implementation of guidelines is briefly discussed, explaining how we used online tools for this in Mexico. Conclusions: Countries where European and American AIT extracts are available should adjust AIT according to which school is followed

Hacia una práctica de aprendizaje-servicio a través de la literatura y el cine en el Grado de Estudios Ingleses: herramientas pedagógicas y educativas para desmantelar discursos colectivos de miedo

Memoria ID-096. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2019-2020.[ES]El objetivo del proyecto es fomentar el aprendizaje-servicio en el Grado de Estudios Ingleses, en temáticas consideradas no canónicas (literaturas y cines postcoloniales de diversidad racial, de género y sexual) para estudiar y promover análisis e intervenciones sobre cómo constructos culturales y performativos vertebran discursos de miedo, y establecer dinámicas de intervención, ordenación y, en la mayoría de los casos, subalternida

Prácticas de Aprendizaje-servicio a través de la literatura y el cine en el Grado de Estudios Ingleses: Creación de un archivo virtual de pedagogías y acciones disidentes contra los discursos de miedo

Memoria ID-067 Ayudas de la Universidad de Salamanca para la innovación docente, curso 2020-2021

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

¿Quién se ha sentido así? Fomentando la vulnerabilidad y la esperanza transformadora en el conocimiento activista del Grado de Estudios Ingleses

Memoria ID2022-112. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2022-2023